Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NRDS | NFGC |
|---|---|---|
| Price | $9.09 | $1.51 |
| Change today | ▲ 2.54% | ▼ 5.63% |
| Market cap | $580.74M | $580.38M |
| Return, 3 months | -5.6% | -0.7% |
| Return, year to date | -33.0% | -49.2% |
| Return, 1 year | -14.1% | -41.9% |
| P/E (TTM) | 10.1 | -9.8 |
| P/B | 1.8 | 1.6 |
| P/E percentile vs own 5y | 56th | 67th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +5.6% | – |
| Net profit growth (YoY) | -47.6% | -4.9% |
| Gross margin | 93.5% | 11.1% |
| Operating margin | 10.2% | -232.9% |
| Net margin | 7.6% | -185.4% |
| Return on equity | 18.2% | -19.4% |
| Analyst target vs. price | +28.5% | +231.1% |
| Analyst buy share | 80% | 100% |
| RSI (14) | 52 | 36 |
| 30-day volatility | 36.1% | 58.4% |
| Max drawdown, 1 year | -52.4% | -60.9% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
